Metraipolis › archive › dc_68d19d41ce91

Efficacy and safety of PD-1 inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis — Europe PMC PMID:42327668

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42327668
DOI
10.3389/or.2026.1745071
License (as archived)
solo-consultazione
Archived
2026-10-31T18:19:46.944Z
SHA-256 of the archived text
de23606eff9fb9fe20e739ee54660fd31aa651f9c76f4eadd57a9d52cac0b3bc
Stable URL of this page
https://metraipolis.com/documento/dc_68d19d41ce91

How to cite

Efficacy and safety of PD-1 inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis — Europe PMC PMID:42327668 — Europe PMC (en), https://europepmc.org/article/MED/42327668 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68d19d41ce91 (Metraipolis archive dc_68d19d41ce91, sha256 de23606eff9fb9fe20e739ee54660fd31aa651f9c76f4eadd57a9d52cac0b3bc)
BibTeX
@misc{dc68d19d41ce91,
  title = {Efficacy and safety of PD-1 inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis — Europe PMC PMID:42327668},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42327668},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68d19d41ce91; sha256 de23606eff9fb9fe20e739ee54660fd31aa651f9c76f4eadd57a9d52cac0b3bc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42327668. Agents can read the archived copy with the MCP tool read_document.